Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Occidental Petroleum releases 2026 Sustainability Report Executive Summary

Occidental Petroleum releases 2026 Sustainability Report Executive Summary

ReutersReuters2026/08/31 19:04
  • Occidental Petroleum outlined a four-pillar sustainability framework spanning governance, people, planet, prosperity, tied to strategic planning and risk management.
  • 2025 methane intensity reached 0.2% of operated wet gas, meeting its <0.25% target, down 64% from 2019.
  • Routine flaring fell 82% since 2020, with sustained zero routine flaring across U.S. operations, extending to three blocks in Oman.
  • Construction finished on central processing facilities for the STRATOS direct air capture project, with EPA Class VI permits secured for CO2 sequestration.
  • Longer-dated targets include eliminating routine flaring by 2030, <0.2% methane intensity by 2030, net-zero for direct and indirect energy-use emissions by 2040.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OXY - Occidental Petroleum Corporation published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage